The FY26 Toxic Exposures Research Program Clinical Trial Award supports clinical trials that aim to prevent, treat, or manage conditions from military-related toxic exposures. It funds projects ranging from small proof-of-concept trials to large-scale efficacy studies. The award encourages interdisciplinary partnerships through a Partnering Principal Investigator Option to accelerate clinical application of promising interventions.
Open to any type of entity, with possible clarifications in additional eligibility information. No specific restrictions stated.
